Document is current
Any future updates will be listed below
-
Authors
Roberts, Jason A. https://orcid.org/0000-0001-6218-435X
Ulldemolins, Marta
Liu, Xin
Baptista, João P.
Bilgrami, Irma
Boidin, Clement
Brinkmann, Alexander
Castro, Pedro
Choi, Gordon
Cole, Louise
De Waele, Jan J.
Deans, Renae
Donnellan, Sine
Eastwood, Glenn M.
Frey, Otto R.
Goutelle, Sylvain
Gresham, Rebecca
Jamal, Janattul Ain
Joynt, Gavin M.
Kanji, Salmaan
Kluge, Stefan
König, Christina
Koulouras, Vasilios P.
Lassig-Smith, Melissa
Laterre, Pierre-Francois
Lee, Anna
Lefrant, Jean-Yves
Lei, Katie
Leung, Patricia
Llaurado-Serra, Mireia
Martin-Loeches, Ignacio
Nor, Mohd Basri Mat
Mudaliar, Yugan
Ostermann, Marlies
Paul, Sanjoy K.
Peake, Sandra L.
Rello, Jordi
Roberts, Darren M.
Roberts, Michael S.
Richards, Brent
Rodríguez, Alejandro
Roehr, Anka C.
Roger, Claire
Seoane, Leonardo
Sinnollareddy, Mahipal
Sousa, Eduardo
Soy, Dolors
Spring, Anna
Starr, Therese
Stephens, Dianne
Taccone, Fabio Silvio
Thomas, Jane
Turnidge, John
Valkonen, Miia
Varghese, Julie M.
Wallis, Steven C.
Walker, Robert J.
Williams, Tricia
Wilson, Luke C.
Wittebole, Xavier
Wright, Daniel F. B.
Zikou, Xanthi T.
Bellomo, Rinaldo
Lipman, Jeffrey
,
Andresen, Max
Baltazar, Sónia F.
Barbar, Saber
Costa, Eulália
Durand, Dominique
Freitas, Ricardo
Valero, Yarmarly Guerra
Haughton, Margaret
Koeberer, Andreas
Kollef, Marin
Klein, Kerenaftali
Mehta, Ravindra
McKenzie, Cathy
Muller, Laurent
Nair, Priya
Nayyar, Vineet
Mejia, Jenny L. Ordóñez
Panagou, Georgia-Laura
Paxton, Jody
Peck, Leah
Vincent, Jean-Louise
Wan, Ruth
Young, Helen
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1044941, APP2009736)
Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK 14106614)
The University of Queensland
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 25 July 2025
First Online: 13 August 2025
Declarations
:
: JAR acknowledges consultancies, grant or speaking fees from Sandoz, Qpex, Gilead, Advanz Pharma, Pfizer, MSD, and Biomerieux. CK reports honoraria for speaking/advisory boards from Shionogi and Gilead. SK received research support from CytoSorbents and Daiichi Sankyo. SK also received lecture fees from ADVITOS, Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer, Shionogi, and ZOLL. SK received consultant fees from Fresenius Medical Care, Gilead, MSD, and Pfizer. MO received research funding from Biomerieux and Baxter (paid to institution). CR received speaker fees from MSD, Pfizer, Shionogi, AOP Orphan, bioMérieux, and Advanz Pharma. CR received fees as Advisory Board member from Advanz Pharma, bioMérieux, and Viatris. JDW has consulted for Biomerieux, Menarini, MSD, Pfizer, Roche Diagnostics, ThermoFisher, and Viatris (fees and honoraria paid to institution).
: The study was designed and conducted following the declaration of Helsinki guidelines and received ethics approval from the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (HREC/13/QRBW/1) as the lead site. All other participating sites also obtained individual HREC approval.
: The authors would like to acknowledge and honour the extraordinary contribution of Professor Rinaldo Bellomo not only to this project but to the broader field of medical research dedicated to the care of the critically ill patient. His exceptional career in clinical practise, research, and mentorship has resulted in major advancements in intensive care medicine and has profoundly impacted the careers and lives of many healthcare professionals around the globe. With the present work, we would like to pay tribute to his unique individual.
